C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2011
11/29/2011	US8067407 Substituted dihydropyrazolones and their use
11/29/2011	CA2661334C Pyrimidone compounds as gsk-3 inhibitors
11/29/2011	CA2522535C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2465757C Triazole derivatives as cyclooxygenase (cox) inhibitors
11/29/2011	CA2438524C Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
11/29/2011	CA2232626C Novel affinity ligands and their use
11/24/2011	WO2011146595A2 Zwitterionic reagents
11/24/2011	WO2011146401A1 Novel inhibitors of hepatitis c virus replication
11/24/2011	WO2011146182A1 Fungicidal oximes and hydrazones
11/24/2011	WO2011145747A1 Prodrug of triazolone compound
11/24/2011	WO2011144742A1 Novel pyrimidine derivatives
11/24/2011	WO2011144666A1 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives
11/24/2011	WO2011090738A3 Type ii raf kinase inhibitors
11/24/2011	WO2011082267A3 Substituted triazolo-pyrazine compounds
11/24/2011	WO2011038097A3 Indolizine inhibitors of 5-lipoxygenase
11/24/2011	US20110288239 Polymeric polyamines and method for producing the same
11/24/2011	US20110288139 Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture
11/24/2011	US20110288116 Iap inhibitors
11/24/2011	US20110288109 New compounds
11/24/2011	US20110288104 Beta-3 receptor ligands and their use in therapy
11/24/2011	US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
11/24/2011	US20110288082 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
11/24/2011	US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011	US20110288076 Sphingosine-1-Phosphate Receptor Antagonists
11/24/2011	US20110288071 Substituted pyrimidines for the treatment of diseases such as cancer
11/24/2011	US20110288065 Aminopyrazine derivative and medicine
11/24/2011	US20110288054 Compounds for the treatment of inflammatory disorders
11/24/2011	US20110287999 Optical brighteners and compositions comprising the same
11/24/2011	US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
11/24/2011	US20110286961 Hepatitis C Virus Inhibitors
11/24/2011	US20110286933 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
11/24/2011	US20110284835 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same
11/24/2011	CA2799390A1 Prodrug of triazolone compound
11/23/2011	EP2388842A1 Organic electroluminescent element
11/23/2011	EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators
11/23/2011	EP2388259A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
11/23/2011	EP2387577A2 Non-peptidyl, potent, and selective mu opioid receptor antagonists
11/23/2011	EP2387568A1 Novel benzotriazole derivatives useful for the treatment of cns disorders
11/23/2011	EP2387565A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
11/23/2011	EP2306990B1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide
11/23/2011	EP2215058B1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
11/23/2011	EP2035391B1 Indazole derivatives for treating hsp90-induced diseases
11/23/2011	EP1993554B1 Urotensin ii receptor antagonists
11/23/2011	EP1940789B1 Methods and compounds for preparing cc-1065 analogs
11/23/2011	EP1937259B1 Hexahydro-cycloheptapyrazole cannabinoid modulators
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	CN102256966A Soluble mtor complexes and modulators thereof
11/23/2011	CN102256965A Pyrimidin-2-ylamino derivatives and their use to treat inflammation
11/23/2011	CN102256964A Compuestos inhibidores de quinasa map p38
11/23/2011	CN102256963A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
11/23/2011	CN102256961A Pyrrole derivatives for use as plant growth regulators
11/23/2011	CN102256944A Sphingosine-1-phosphate receptor antagonists
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN102250070A New method for preparing key intermediate of voriconazole
11/23/2011	CN102250069A Pyrrolic amide compound and purpose thereof in preparation of anti-malignant tumor medicament
11/23/2011	CN102250068A Preparation method for 1-methyl-4-(2-methyltetrazole-5-group)-5-sulfonylchloropyrazole
11/23/2011	CN102250065A Substituted triazine phenyl urea derivatives and application thereof
11/23/2011	CN102250022A Substituted quinoxalinamine compounds, and preparation method and application thereof
11/23/2011	CN102249982A Novel pleuromutilin compound, and medical composition, preparation method and application thereof
11/22/2011	US8063230 Tris(N-aryl benzimidazole)benzenes and their use in electronic devices
11/22/2011	US8063068 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
11/22/2011	US8063058 Inhibitors of syk and JAK protein kinases
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	US8063044 Pyrazole derivatives
11/22/2011	US8063042 Heterocyclic compounds
11/22/2011	US8063041 Polymorphic Form D of bazedoxifene acetate and methods of preparing same
11/22/2011	US8063038 Heterocyclic condensed compounds useful as antidiuretic agents
11/22/2011	CA2515546C Pyrrolidine derivatives as oxytocin antagonists
11/22/2011	CA2510807C Inhibitors of tace
11/22/2011	CA2509151C Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
11/22/2011	CA2471974C Quinazolinone derivatives and their use as cb agonists
11/17/2011	WO2011143495A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011143430A1 Indazole inhibitors of kinase
11/17/2011	WO2011143423A2 Compounds useful as inhibitors of atr kinase
11/17/2011	WO2011143419A1 Pyrazines useful as inhibitors of atr kinase
11/17/2011	WO2011143366A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	WO2011143365A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/17/2011	WO2011143163A1 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
11/17/2011	WO2011143162A1 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
11/17/2011	WO2011143155A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
11/17/2011	WO2011143150A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
11/17/2011	WO2011143145A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
11/17/2011	WO2011143129A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors
11/17/2011	WO2011143033A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
11/17/2011	WO2011142329A1 Complex compound and optical recording medium containing same
11/17/2011	WO2011142316A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity
11/17/2011	WO2011141909A2 Lipoic acid and nitroxide derivatives and uses thereof
11/17/2011	WO2011082271A3 Substituted triazolo-pyrimidine compounds
11/17/2011	US20110282018 Process for selectively polymerizing ethylene and catalyst therefor
11/17/2011	US20110281910 Hepatitis C Virus Inhibitors
11/17/2011	US20110281899 Methods of preventing and treating low bone mass diseases
11/17/2011	US20110281881 Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
11/17/2011	US20110281876 Therapeutic agents useful for treating pain
11/17/2011	US20110281875 Inhibitors of IAP
11/17/2011	US20110281873 Pyrimidine Compounds and Methods of Making and Using Same
11/17/2011	US20110281872 Compositions and methods for the prevention and treatment of cancer
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers

1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 626